Q-Square Business Intelligence

Q Square Business Intelligence

Pharmaceuticals, 310 Flagg Hl Rd, Boxborough, Massachusetts, 01719, United States, 201-500 Employees

q2bi.com

  • LinkedIn

Who is Q-SQUARE BUSINESS INTELLIGENCE

Q-square Business Intelligence, Corp. (Q2BI) is a biometrical and clinical science contract research organization (CRO) for biopharmaceutical product/drug development and regulatory submi...

Read More

map
  • 310 Flagg Hl Rd, Boxborough, Massachusetts, 01719, United States Headquarters: 310 Flagg Hl Rd, Boxborough, Massachusetts, 01719, United States
  • 2009 Date Founded: 2009
  • 201-500 Employees: 201-500
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 8071

checked-icon Does something look wrong? Fix it. | View contact records from Q-SQUARE BUSINESS INTELLIGENCE

Q-Square Business Intelligence Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Q-Square Business Intelligence

Answer: Q-Square Business Intelligence's headquarters are located at 310 Flagg Hl Rd, Boxborough, Massachusetts, 01719, United States

Answer: Q-Square Business Intelligence's official website is https://q2bi.com

Answer: Q-Square Business Intelligence's revenue is $1 Million to $5 Million

Answer: Q-Square Business Intelligence's SIC: 8071

Answer: Q-Square Business Intelligence has 201-500 employees

Answer: Q-Square Business Intelligence is in Pharmaceuticals

Answer: Q-Square Business Intelligence contact info: Phone number: Website: https://q2bi.com

Answer: Q-square Business Intelligence, Corp. (Q2BI) is a biometrical and clinical science contract research organization (CRO) for biopharmaceutical product/drug development and regulatory submissions, with a broad range of expertise-based services in the areas of electronic data capture (EDC), clinical data management (CDM), medical coding (MC), Statistical Programming, Biostatistical science, safety monitoring including IDMC/DSMB, Pharmacokinetics/Pharmacodynamics (PK/PD) and Consulting since 2009. Q2BI covers all clinical phase studies as well as regulatory submission-needed Biostatistics/Programming/Data Management (BPDM) services. Q2BI has been a global CRO since 2009 and has grown steadily over years with long-term service for and partnerships with many well-established as well as newly emerged companies in the biopharmaceutical world. Operating in North America (with footprint in greater New York, Boston, and San Francisco metropolitan areas) , Q2BI has won its reputation for its high quality, flexibility, excellent service and harmonized collaborations in meeting the needs and achieving the expectations of variety sized of pharmaceutical clients. At Q2BI, we put great endeavor in helping, understanding and meeting the scientific aspects of any in-contract development project, with priority focus on high quality of our work and deliverables. We trust our employees are the greatest talent and asset, who are provided with unique, project sponsors-based business owner (BO) system and project-team setting for daily performances and demonstrations. Q2BI team has experienced over 1000 studies and 34 successful NDA/BLA submission approvals in various therapeutic areas. Q2BI is a pioneer in adopting CDISC and Q2BI team supported the world first FDA Project ORBIS.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access